Trade LIXT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Lixte Biotechnology Holdings Inc (LIXT) is trading at US$7.21, up 0.00% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$125.36M. Over the past 52 weeks, LIXT has traded between US$2.36 and US$8.38. On Syfe you can trade LIXT with $0 commission and add it to your watchlist.
| Previous close | US$7.21 |
|---|---|
| Market cap | US$125.36M |
| 52-week range | US$2.36 – US$8.38 |
| Volume | 615.06K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Lixte Biotechnology Holdings Inc
Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets. The company was founded by John S. Kovach and Robert B. Royds on May 24, 2005 and is headquartered in Boca Raton, FL.
Year: 2007
Lixte Biotechnology to Acquire Nomad Power Systems; to Change Name After Acquisition
Jun 12, 1:28 PM · MT Newswires
Lixte Biotechnology Prices $16.6 Million Registered Direct Offering Priced at the Market
Jun 3, 1:19 PM · MT Newswires
Lixte Biotechnology Holdings Inc (LIXT) stock is trading at US$7.21, 0.00% from the previous close of US$7.21.
The market cap for Lixte Biotechnology Holdings Inc (LIXT) stock is approximately US$125.36M.
The 52-week high for Lixte Biotechnology Holdings Inc (LIXT) stock is US$8.38.
The 52-week low for Lixte Biotechnology Holdings Inc (LIXT) stock is US$2.36.
Lixte Biotechnology Holdings Inc (LIXT) does not currently pay a dividend.
Stay on top of LIXT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
